Calcimar, Forcaltonin(calcitonin salmon)
Calcitonin Salmon, Forcaltonin, Fortical, Miacalcin (calcitonin salmon) is a protein pharmaceutical. Calcitonin salmon was first approved as Calcimar on 1982-01-01. It has been approved in Europe to treat bone resorption, hypercalcemia, and osteitis deformans. The pharmaceutical is active against calcitonin receptor.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Trade Name
FDA
EMA
Calcitonin-salmon, Miacalcin (discontinued: Calcimar, Calcitonin-salmon, Fortical, Miacalcin)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Calcitonin salmon
Calcitonin salmon recombinant
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| FORTICAL | Upsher-Smith Laboratories | N-021406 DISCN | 2005-08-12 | 1 products |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| calcitonin salmon | ANDA | 2024-12-13 |
| calcitonin-salmon | 2008-11-28 | |
| fortical | New Drug Application | 2010-01-15 |
| miacalcin | New Drug Application | 2021-08-15 |
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
H: Systemic hormonal preparations, excl. sex hormones and insulins
— H05: Calcium homeostasis
— H05B: Anti-parathyroid agents
— H05BA: Calcitonin preparations
— H05BA01: Calcitonin (salmon synthetic)
— H05BA02: Calcitonin (pork natural)
— H05BA03: Calcitonin (human synthetic)
N: Nervous system drugs
— N02: Analgesics
— N02C: Antimigraine preparations
— N02CD: Calcitonin gene-related peptide (cgrp) antagonists
HCPCS
Code | Description |
|---|---|
| J0630 | Injection, calcitonin salmon, up to 400 units |
Clinical
No data
Drug
General
| Drug common name | Calcitonin salmon |
| INN | — |
| Description | Forcaltonin, Fortical, Miacalcin (calcitonin salmon) is a protein pharmaceutical. Calcitonin salmon was first approved as Calcimar on 1982-01-01. It has been approved in Europe to treat bone resorption, hypercalcemia, and osteitis deformans. The pharmaceutical is active against calcitonin receptor. |
| Classification | Protein |
| Drug class | vitamin D analogs; anti-inflammatory agents (salicylic acid derivatives) |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(N)=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O |
Identifiers
| PDB | — |
| CAS-ID | 9007-12-9 |
| RxCUI | — |
| ChEMBL ID | CHEMBL3989767 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | DB00017 |
| UNII ID | — |
Target
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use